BridgeMD
Efficacy and safety of Ropivacaine injection in the management of post-operative pain: A comparison of plane block versus wound infiltration for post-operative analgesia in lumbar arthrodesis surgery.
EU CTIS ID: 2024-511406-23-00
What this study is testing
Determine the reduction in morphine consumption in mg
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Participant must be ≥18 years old at the time of signing the Informed Consent
- To have a lumbar arthrodesis programmed at the Hospital Universitari Arnau de Vilanova de Lleida
- ASA grade I-III
- Participant must be capable of giving Informed Consent
You likely can't join if
- Specific contraindications for Ropivacaine treatment
- Other medical conditions or comorbidities which, in the opinion of the Investigator, would interfere with study compliance or data interpretation
- Mujeres embarazadas o en periodo de lactancia
- IMC >35
- Known medical history or evidence of severe liver disease and/or renal impairment (eGFR <30).
- Previous back surgery
See the full eligibility criteria
- Participant must be ≥18 years old at the time of signing the Informed Consent
- To have a lumbar arthrodesis programmed at the Hospital Universitari Arnau de Vilanova de Lleida
- ASA grade I-III
- Participant must be capable of giving Informed Consent
- Specific contraindications for Ropivacaine treatment
- Other medical conditions or comorbidities which, in the opinion of the Investigator, would interfere with study compliance or data interpretation
- Mujeres embarazadas o en periodo de lactancia
- IMC >35
- Known medical history or evidence of severe liver disease and/or renal impairment (eGFR <30).
- Previous back surgery
- Evidence of immunological diseases
- Evidence of malignancy
- Systemic active infection that requires treatment
- Skin disease at the puncture site
- Active psychiatric disorder, including, but not limited to schizophrenia, bipolar disorder, or severe depression requiring current pharmacological intervention
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.